Burjeel Holdings PLC (ADX: BURJEEL), the ADX-listed healthcare group, has acquired a 100% stake in PhysioTrio Physiotherapy Center, a Riyadh-based specialist in sports rehabilitation. The acquisition, conducted through its subsidiary Burjeel Arabia, integrates PhysioTrio into Burjeel’s rapidly growing PhysioTherabia network in Saudi Arabia.
PhysioTrio holds key partnerships, including contracts with the Saudi Ministry of Sport, positioning Burjeel to enhance its cutting-edge sports rehabilitation services in the Kingdom. With this latest addition, the PhysioTherabia network now operates across 30 facilities in Saudi Arabia.
Burjeel initially launched PhysioTherabia in 2023 in partnership with Saudi Arabia’s Leejam Sports Company, establishing centers that offer a range of sports rehabilitation and physical therapy services. The network has expanded significantly, with eight new PhysioTherabia centers inaugurated last year across major Saudi cities, including Riyadh, Jeddah, Dammam, Al Khobar, and Yanbu. Earlier this year, Burjeel KSA, another Saudi subsidiary, also fully acquired the Makkah-based Specialist Physiotherapy Center for SAR 6.5 million.
A spokesperson for Burjeel Holdings indicated that the firm aims to expand its PhysioTherabia network to 60 facilities. Beyond Saudi Arabia, Burjeel is also planning a new hospital in Dubai, as well as new medical centers in Al Ain, Fujairah, and Riyadh.
This acquisition is part of a broader expansion drive by Burjeel Holdings. In the past month, the healthcare provider launched Alkalma, a regional mental health and wellbeing platform, by integrating four specialist centers across Dubai, Abu Dhabi, and Riyadh. Other recent initiatives include the launch of a Genetics and Rare Disease Center at Burjeel Medical City, an oncology center in Sharjah, and a specialized center for blood disorders in Abu Dhabi. Earlier this year, the company also acquired an 80% stake in Dubai’s Advanced Care Oncology Center (ACOC) for AED 92 million.
